Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors
NCT05584449
Summary
This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Many AYA survivors typically do not feel prepared to re-enter "daily life" and would likely benefit from structured interventions to offer education and support in a timely manner as to prepare them for the challenges of life in survivorship. A 6-week group curriculum, designed to specifically meet the needs of AYA cancer survivors and facilitated by licensed social workers, may meet the unique needs of young adults who have survived a cancer diagnosis, and if so, the curriculum could be licensed and used across Mayo Clinic sites and potentially at other cancer centers nationwide.
Eligibility
Inclusion Criteria: * Age 18-39 * Is a patient of Mayo Clinic Arizona for oncologic care and/or follow-up * History of cancer diagnosis * Treated with curative intent * Completed cancer treatment within 6 months to 2 years prior to group attendance * Ability to read/write/speak English * Ability to participate in a group setting * Ability to commit to attending all six group meetings Exclusion Criteria: * Inability to read/write/speak English * No internet or computer access * Not receiving care at Mayo Clinic Arizona * Currently receiving treatment for cancer * Is unable to sit comfortably for 90 minutes * Was not treated with curative intent * Is on hospice care * Co-morbid systemic illness or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study or interfere significantly with the proper assessments
Conditions3
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05584449